dactinomycin has been researched along with Myelodysplastic Syndromes in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ | 1 |
| Hokland, P; Holm, M; Høyer, M; Thomsen, M | 1 |
| Ahrens, S; Dunst, J; Harms, D; Jürgens, H; Paulussen, M; Rübe, C; Winkelmann, W; Zoubek, A | 1 |
| Pallis, M; Russell, NH; Syan, J | 1 |
| Buchanan, GR; Pappo, A; Sanders, JM; Schneider, NR | 1 |
1 review(s) available for dactinomycin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Secondary myelodysplastic syndrome complicating therapy for osteogenic sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Methotrexate; Myelodysplastic Syndromes; Osteosarcoma | 1991 |
4 other study(ies) available for dactinomycin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation | 1995 |
Optimization of a flow cytometric method for the simultaneous measurement of cell surface antigen, DNA content, and in vitro BrdUrd incorporation into normal and malignant hematopoietic cells.
Topics: Acute Disease; Antibodies, Monoclonal; Antigens, CD34; Bone Marrow Cells; Bromodeoxyuridine; Cell Membrane Permeability; Coloring Agents; Dactinomycin; DNA; Flow Cytometry; HLA Antigens; Humans; Leukocytes, Mononuclear; Myelodysplastic Syndromes; Reproducibility of Results; Tissue Fixation; Tumor Cells, Cultured | 1998 |
Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms, Second Primary; Radiotherapy Dosage; Sarcoma; Sarcoma, Ewing; Time Factors; Vincristine | 1998 |
Flow cytometric chemosensitivity analysis of blasts from patients with acute myeloblastic leukemia and myelodysplastic syndromes: the use of 7AAD with antibodies to CD45 or CD34.
Topics: Antibodies; Antigens, CD34; Cell Count; Cytarabine; Dactinomycin; Flow Cytometry; Fluorescent Dyes; Humans; Leukemia, Myeloid, Acute; Leukocyte Common Antigens; Light; Myelodysplastic Syndromes; Scattering, Radiation; Sensitivity and Specificity; Stem Cells; Tumor Cells, Cultured | 1999 |